💪 Muscle Growth & PerformancePhase II

CJC-1295

Modified GRF 1-29 · GHRH Analog

A long-acting GHRH analog for sustained growth hormone release

Typical Dose

1–2 mg per week

Route

Subcutaneous

Frequency

Once or twice per week

Cycle

8–12 weeks

CJC-1295 peptide hero image

Overview

CJC-1295 is a modified version of a hormone your brain naturally uses to tell your pituitary gland to release growth hormone. The original version of this signal lasts only minutes in your body. CJC-1295 was engineered to last days by attaching to a blood protein called albumin, which acts like a slow-release carrier. The result is a steady, sustained increase in growth hormone over time, rather than a quick spike. It is almost always used together with Ipamorelin for a synergistic effect.

Key Benefits

Increases growth hormone and IGF-1 levels
Promotes lean muscle mass gain
Reduces body fat
Improves sleep quality and recovery
Enhances protein synthesis
Anti-aging effects

Mechanism of Action

CJC-1295 docks onto the GHRH receptor in your pituitary gland — the same receptor your brain's natural growth hormone signal uses. This tells the pituitary to produce and release growth hormone. What makes CJC-1295 different from the natural signal is its DAC modification, which lets it attach to albumin (a blood protein) and hitch a ride through your bloodstream for days instead of minutes. This keeps growth hormone levels elevated in a sustained, natural-feeling way rather than a sharp spike.

Dosing Protocol

Typical Dose

1–2 mg per week

Dose Range

1–2 mg/week

Frequency

Once or twice per week

Route

Subcutaneous injection

Cycle Length

8–12 weeks

CLINICAL NOTES

Almost always stacked with Ipamorelin for synergistic GH release. The combination provides a more natural, pulsatile GH release pattern.

Save to Library

Reconstitution calculator and cycle planner pre-filled with CJC-1295 defaults

Side Effects & Safety

Water retention
Tingling or numbness
Fatigue
Injection site reactions
Potential insulin resistance at high doses

IMPORTANT DISCLAIMER

This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol. Individual responses vary and medical supervision is recommended.

Research References

Common Stacks

CJC-1295 is almost always paired with a GHRP like Ipamorelin for synergistic GH release.

Frequently Asked Questions

Quick Reference

CategoryMuscle Growth & Performance
Research StatusPhase II
Typical Dose1–2 mg per week
RouteSubcutaneous
Cycle8–12 weeks
Opens a print dialog. Choose Save as PDF as the destination to download a clean one-page PDF.

Community Reviews

Real experiences from the Peptide Insights community

Have you used CJC-1295?

Real experiences from real people help others make informed decisions. Share what worked, what didn't, and what you wish you'd known before starting.

Dosing insightsResults timelineSide effectsStack combinations
Sign In to Share Your Experience

Free account required. Your review helps the Peptide Insights community.

No reviews yet for CJC-1295

Be the first to share your experience. Your insight could help someone else decide if CJC-1295 is right for them.

Sign In to Be the First
Free Guide

Want to go deeper on CJC-1295?

Get our free 32-page Beginner's Guide — plain-language breakdowns of the top peptides, dosing essentials, and safety basics.

Free Beginner's Guide

32-page PDF, instant download

No spam. Unsubscribe anytime.